Abatacept Bone Effects in Psoriatic Arthritis with Bone Biomarker – ABEPSA_BB
Latest Information Update: 05 Oct 2022
At a glance
- Drugs Abatacept (Primary)
- Indications Psoriatic arthritis
- Focus Therapeutic Use
- Acronyms ABEPSA-BB
Most Recent Events
- 02 Oct 2022 Status changed from recruiting to discontinued.
- 17 May 2018 New trial record